Sage Therapeutics
@SageBiotech
Followers
3K
Following
101
Media
693
Statuses
1K
Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. Community Guidelines: https://t.co/O3kvO0DUOA
Cambridge, MA
Joined January 2016
Join us today at 4:30 pm ET for our first quarter 2025 financial results via conference call and webcast: $SAGE
0
0
0
We will present financial results for the first quarter of 2025 on Tuesday, April 29, 2025 at 4:30 PM ET via live webcast and conference call. Learn more: $SAGE
0
0
0
We support @MMHLA2’s first-ever National #DayofAction for #MaternalMentalHealth. About 1 in 8 women report experiencing symptoms of #postpartumdepression, yet many lack support. Together, we can help drive lasting change by raising awareness and advocating for better care.
0
0
0
Join us today at 4:30 pm ET for our fourth quarter and full year 2024 financial results via conference call and webcast: $SAGE
0
0
0
We will present financial results for the fourth quarter and full year of 2024 on Tuesday, February 11, 2025 at 4:30 PM ET via live webcast and conference call. Learn more: $SAGE
0
0
0
On December 4th, join us for our fireside chat at the 2024 @Piper_Sandler Healthcare Conference. The #LIVE webcast begins streaming at 9:00 AM ET. Watch here: $SAGE
2
0
1
This week at @PsychCongress, Sage Therapeutics, in partnership with @NAMICommunicate and @Biogen, shared new insights into #postpartumdepression (PPD) and its impact on women and families. . We're proud to announce that our joint research poster focused on the burden of PPD has
3
1
3
Join us today at 4:30 pm ET for our third quarter financial results via conference call and webcast: $SAGE
6
0
0
The Sage team is excited to attend @PsychCongress this week. We look forward to connecting with industry leaders dedicated to improving the diagnosis and treatment of maternal mental health and postpartum depression (PPD)...Learn more here:
0
1
3
Update: We will present third quarter financial results on October 29th, 2024 at 4:30 pm ET via live webcast and conference call. Learn more: $SAGE
0
0
0
Today, we announced topline results from our Phase 2 LIGHTWAVE study in the treatment of mild cognitive impairment in Alzheimer’s disease. Read more:
0
0
0
We are incredibly honored to share that Sage Therapeutics, in collaboration with our partners at @biogen, has been named a winner for @PM360online's prestigious Trailblazer Award in the “Product Launch of the Year” category for our work in #PostpartumDepression.
3
0
9
This weekend, the Sage team will be attending @EHDN_News & Enroll-HD 2024 in France. We look forward to sharing our #HuntingtonsDisease (HD) research, including an overview of our HD clinical studies. #EHDN2024
0
4
9
Join us today at 4:30 pm ET for our second quarter financial results via conference call and webcast: $SAGE
0
0
1
With our partner, @Biogen, today we announced topline results from the KINETIC 2 Study in Essential Tremor. Read more:
0
0
1
Update: We will present second quarter financial results on Wednesday, July 31st, 2024 at 4:30 pm ET via live webcast and conference call. Learn more: $SAGE
0
0
2
We are proud to share that Matt Lasmanis, Sage's Chief Technology and Innovation Officer, has been named to @constellationr's #BT150 list! Learn more:
3
1
4
This morning, we provided an update on our #HuntingtonsDisease program. Read the latest news here:
2
0
1
We're looking forward to attending @GoldmanSachs 45th Annual Global Healthcare Conference on June 12th. Join us for a fireside chat at 2:00 pm ET here:
0
0
3